Article Details
Retrieved on: 2024-12-07 13:11:29
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the significant growth of the Heart Failure POC & LOC Devices market, driven by advancements in healthcare technology such as microfluidics and AI. It highlights the role of biotechnological innovations like lab-on-a-chip and personalized medicine in enhancing diagnostic capabilities for heart failure. The integration of these technologies with chemical pathology and IoT promotes better monitoring and management of medical signs and biomarkers, especially at the point of care.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here